Ioannis Parodis

May 15, 2024 | ard.bmj.com | Ioannis Parodis |Charlotte Girard-Guyonvarc’h |Laurent Arnaud |Oliver Distler

Based on the results from the SLR and mainly driven by the overall CA, but also expert opinion, overarching principles and recommendation statements were proposed by the steering committee and were presented and discussed with the task force members at four consecutive online meetings in May and June 2022. In these meetings, 23, 20, 17 and 16 of 25 task force members participated, respectively.

Apr 9, 2024 | lupus.bmj.com | Ioannis Parodis

Lupus Erythematosus, SystemicLupus NephritisTherapeuticsAntirheumatic AgentsIntroductionSLE is a complex autoimmune disease, characterised by a prominent clinical heterogeneity,1 with lupus nephritis (LN) standing as one of its most severe manifestations.2 Despite significant advances in understanding SLE pathogenesis, the precise role of circadian rhythm disruption (CRD) in SLE and particularly its link to LN has remained elusive.

Feb 15, 2024 | lupus.bmj.com | Laurent Arnaud |Ioannis Parodis |Hervé Devilliers |Francois Chasset

Clinical trial outcomes for SLE: what we have and what we need Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Sep 1, 2023 | ard.bmj.com | Ioannis Parodis |Charlotte Girard-Guyonvarc’h |Laurent Arnaud |Oliver Distler

Systemic Lupus ErythematosusSystemic SclerosisPatient perspectivePatient Reported Outcome MeasuresPatient Care TeamWhat is already known about this subject? Non-pharmacological management of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) is helpful but unstandardised and often underused in current clinical practice. What does this study add?

Jul 10, 2023 | ard.bmj.com | Ioannis Parodis |Charlotte Girard-Guyonvarc’h |Laurent Arnaud |Oliver Distler

Formulation of overarching principles and recommendation statementsBased on the results from the SLR and mainly driven by the overall CA, but also expert opinion, overarching principles and recommendation statements were proposed by the steering committee and were presented and discussed with the task force members at four consecutive online meetings in May and June 2022. In these meetings, 23, 20, 17 and 16 of 25 task force members participated, respectively.